Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 6Phase 3 4Phase 1/2 3Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 210Bone Neoplasms 58Neoplasms 39Breast Neoplasms 39Osteosarcoma 37Lymphoma 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Gastrointestinal Stromal Tumors 31Dendritic Cell Sarcoma, Interdigitating 31Hodgkin Disease 29Lymphoma, Non-Hodgkin 27Leukemia 27Burkitt Lymphoma 25Melanoma 24Brain Neoplasms 24Multiple Myeloma 23Leukemia, Myeloid, Acute 23Sarcoma, Ewing 22Recurrence 21Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Glioblastoma 21Neuroblastoma 20Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma, Large-Cell, Immunoblastic 18Gliosarcoma 18Sarcoma, Kaposi 17Prostatic Neoplasms 17Pancreatic Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinosarcoma × Sarcoma × Clear all
NCT04458597 2025-08-01

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
23 enrolled
Sarcoma

Carcinosarcoma, Adenocarcinoma, Clear Cell, Carcinoma, Endometrioid, Cystadenocarcinoma, Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡